Printer Friendly
The Free Library
14,610,849 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Research and Markets: Barr Pharmaceuticals is One of the USA's Leading Generic Manufacturers with Sales in Fiscal 2006 Amounted to a Rise of 25% over 2005.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c64326) has announced the addition of Espicom Business Intelligence Introduction
Espicom Business Intelligence is a publisher of independent and impartial information and analysis services focusing on the pharmaceutical and medical device markets.
 Barr Generics Company Intelligence Report to their offering.

Barr Pharmaceuticals Barr Pharmaceuticals, Inc., (NYSE: [http://www.nyse.com/about/listed/lcddata.html?ticker=BRL BRL]) is global specialty pharmaceutical company that operates in more than 30 countries worldwide and is engaged in the development, manufacture and marketing of generic and  is one of the USA's leading generic manufacturers. Generic sales in fiscal 2004 amounted to US$1.15 billion, although a sizeable proportion of this was revenue from distributed products. The company has a policy of early market entry for generics, and as such is generally involved in a large amount of litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
. Sales also tend to fluctuate year on year, as specific exclusivities are gained and expire. Prozac (fluoxetine fluoxetine /flu·ox·e·tine/ (floo-ok´se-ten) a selective serotonin reuptake inhibitor used as the hydrochloride salt in the treatment of depression, obsessive-compulsive disorder, bulimia nervosa, and premenstrual dysphoric disorder. ) is a notable example.

This generics company report will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. This informative report provides an insight into the company, covering the structure of the business, the most recent quarterly and annual financial results, information on the company's active product lines and ANDA ANDA
abbr.
abbreviated new drug application
 approvals, along with a review of major developments, such as M&A activity, strategic alliances, and litigation.

The report is broken down into the following sections:

- Executive Summary

- Introduction

- Products

- Financial Results

- Major Developments

- Contact Details

Barr Pharmaceuticals is one of the USA's leading generic manufacturers. The company has a policy of early market entry for generics, and as such is generally involved in a large amount of litigation. Sales also tend to fluctuate year on year, as specific exclusivities are gained and expire. Fluoxetine and ciprofloxacin ciprofloxacin /cip·ro·flox·a·cin/ (sip?ro-flok´sah-sin) a synthetic antibacterial effective against many gram-positive and gram-negative bacteria; used as the hydrochloride salt.

cip·ro·flox·a·cin
n.
 are notable examples in recent years.

Sales tend to fluctuate from year to year, due to specific product deals and exclusivities. Sales in fiscal 2006 amounted to a rise of 25% over 2005. Much of this rise was due to revenues from product agreements with Teva and Kos Pharmaceuticals.

In June 2006, Barr's offer to acquire Pliva was accepted by the board of the Croatian company. Barr faced strong competition for Pliva from Actavis, although the Icelandic company dropped out of contention after a three month bidding war. The acquisition was completed in October 2006 and will make Barr one of the world's largest generic manufacturers, with an enhanced presence in Europe.

In terms of its own manufacturing, Barr's leading area of expertise is female healthcare, notably oral contraceptives Oral Contraceptives Definition

Oral contraceptives are medicines taken by mouth to help prevent pregnancy. They are also known as the Pill, OCs, or birth control pills.
. Barr's leading OC is Seasonale, an extended cycle oral contraceptive oral contraceptive
n.
A pill, typically containing estrogen or progesterone, that prevents conception or pregnancy. Also called birth control pill.
, which itself began to face generic competition in 2006.

Companies Mentioned:

- Endeavor Pharmaceuticals

- Enhance Pharmaceuticals

- Pliva

- Shire Shire or Shiré (both: shē`rā), river, c.250 mi (400 km) long, flowing from the southern end of Lake Nyasa, Malawi, SE Africa, to the Zambezi River in central Mozambique. It is navigable to Nsanje.  Pharmaceuticals

- Women's Capital Corporation

- Wyeth

For more information visit http://www.researchandmarkets.com/reports/c64326
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 31, 2007
Words:415
Previous Article:Research and Markets: 2007 U.S. Hardware Stores Product Lines.
Next Article:Research and Markets : US Natural Gas Sector: Industry Profile.
Topics:



Related Articles
Monaco has strong 2nd quarter.(Business)(Despite a profitable second quarter, the Coburg-based RV-maker's profits are still behind those of last year)
BUSINESS BEAT.(Business)
Corporate foundations make record contributions.(FUNDRAISING)
How low can Sarbanes-Oxley Section 404 costs go? In the third year of compliance with Section 404, total average costs have dropped an additional 23...
Sumitomo Chemical Reports Consolidated Financial Results for the Three Months Ended June 30, 2007.
Mitsubishi Corporation Announces Consolidated Financial Results for the First Quarter Ended June 30, 2007 (US GAAP).
Sumitomo Chemical to Acquire Cambridge Display Technology Inc.
Asahi Kasei Reports Consolidated Results for 1st Quarter Fiscal 2007.
Mazda Reports First Quarter Financial Results for Fiscal Year 2007; Full-year Forecast on Track.
Pioneer Announces Business Results for 1Q Fiscal 2008.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles